23
Participants
Start Date
October 31, 2005
Primary Completion Date
November 30, 2005
Study Completion Date
inhaled human insulin
Novo Nordisk Investigational Site, Graz
Lead Sponsor
Novo Nordisk A/S
INDUSTRY